Lundbeck
HLUN-B.CO
#2670
Rank
A$9.15 B
Marketcap
A$9.23
Share price
-1.12%
Change (1 day)
23.83%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): A$0.93

According to Lundbeck's latest financial reports the company's current EPS (TTM) is A$0.85. an increase over its 2024 EPS that were of A$0.61.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025A$0.7014.5%
2024A$0.6129.29%
2023A$0.4723.09%
2022A$0.3937.26%
2021A$0.28-84.61%
2020A$1.83-24.61%
2019A$2.42-42.06%
2018A$4.1840.7%
2017A$2.97146.26%
2016A$1.21-120.48%
2015A-$5.893231.32%
2014A-$0.18-115.78%
2013A$1.12-23.36%
2012A$1.46-48.01%
2011A$2.81-9.68%
2010A$3.1113.72%
2009A$2.7424.32%
2008A$2.20-6.05%
2007A$2.3481.77%
2006A$1.29-16.76%
2005A$1.55-17.58%
2004A$1.88